Trials / Sponsors / Do-Youn Oh
Do-Youn Oh
Academic / Other · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | Neoadjuvant CCRT With Gemcitabine/Durvalumab (MEDI4736) Followed by Adjuvant Gemcitabine/Durvalumab(MEDI4736) Pancreatic Cancer | Phase 2 | 2018-11-29 |
| Active Not Recruiting | Biomarker-oriented Study of Durvalumab (MEDI4736) in Combination With Olaparib and Paclitaxel in Gastric Cance Advanced Gastric Cancer | Phase 2 | 2018-11-26 |